Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

Claire Mazumdar

Director & Chief Executive Officer

SEC EDGAR ↗

Director & Chief Executive Officer at Bicara Therapeutics Inc., filing insider transactions between 2026-03-04 and 2026-05-18.

Total Purchases
—
0 transactions
Total Sales
$1.8M
10 transactions
Companies Traded
1
10 total filings
Active Since
2026-03-04
Last: 2026-05-18

Companies

BCAX2026-05-18

Bicara Therapeutics Inc.

↓ $1.8M (10)

Other Reporting Insiders at Bicara Therapeutics Inc.

  • Ryan Cohlhepp
    Director & President, COO & Interim CEO
    Last filing 2026-09-08
  • Ivan Hyep
    Chief Financial Officer
    Last filing 2026-08-10
  • Claire Mazumdar
    Director & Chief Executive Officer
    Last filing 2026-08-10
  • Ivan Hyep
    Chief Financial Officer
    Last filing 2026-05-21
  • Ryan Cohlhepp
    Director & President and COO
    Last filing 2026-05-15
  • David Raben
    Chief Medical Officer
    Last filing 2026-04-27
  • Ra Capital Management, L.p.
    Director
    Last filing 2026-02-26

Transaction History

DateTickerTypeSharesPriceValueOwned After
2026-05-18BCAXSale2,978$20.35$61K362.2KSEC ↗
2026-05-18BCAXSale12.0K$19.96$240K365.1KSEC ↗
2026-04-20BCAXSale15.0K$23.61$354K362.2K
SEC ↗
2026-03-20BCAXSale1,596$18.95$30K339.4KSEC ↗
2026-03-19BCAXSale6,905$18.78$130K339.4KSEC ↗
2026-03-18BCAXSale6,499$18.84$122K339.4KSEC ↗
2026-03-09BCAXSale36.8K$19.17$705K339.4KSEC ↗
2026-03-06BCAXSale3,817$18.75$72K339.4KSEC ↗
2026-03-05BCAXSale1,786$18.74$33K339.4KSEC ↗
2026-03-04BCAXSale2,631$18.73$49K339.4KSEC ↗